Inhibiting MAPK14 showed anti-prolactinoma effect

The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38 α MAPK (MAPK14), p38β (MAPK11),...

Source: BMC Endocrine Disorders - September 7, 2020 Category: Endocrinology Authors: Qiao-yan Ding, Yu Zhang, Li Ma, Yong-gang Chen, Jin-hu Wu, Hong-feng Zhang and Xiong Wang Tags: Research article Source Type: research